.svg){kind=small}
Mar-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Farmaceutical Rx (Frx) has shown varied performance across different product categories in Ohio. In the Concentrates category, the brand experienced fluctuations, starting at a rank of 14 in December 2024, peaking at 11 in January 2025, before declining to 18 by March 2025. This movement indicates a competitive landscape where maintaining a top position requires consistent performance. In contrast, their Flower category showed a more stable trajectory, with ranks moving from 33 in December 2024 to a peak of 28 in February 2025. Such stability in Flower suggests a strong consumer base and consistent demand.
In the Edible category, Farmaceutical Rx (Frx) did not make it into the top 30 brands until March 2025, when they ranked 43, subsequently moving to 47. This late entry into the rankings might suggest challenges in gaining traction or market penetration in this category. Meanwhile, the Vapor Pens category witnessed significant volatility, with ranks dropping from 33 in December 2024 to 61 by March 2025. This decline could reflect a shift in consumer preferences or increased competition. The overall sales data shows that while certain categories like Flower remain strong, others such as Vapor Pens and Edibles present opportunities for strategic improvements.
Competitive Landscape
In the competitive landscape of the Ohio flower category, Farmaceutical Rx (Frx) has shown a consistent presence, albeit with fluctuating rankings. From December 2024 to March 2025, Frx's rank improved from 33rd to 31st, indicating a slight upward trend. However, this improvement is modest compared to competitors like Classix, which experienced more dramatic shifts, such as a drop from 14th to 32nd in January 2025 before recovering to 29th by March. Similarly, Kynd Cannabis Company maintained a relatively stable position, hovering around the mid-20s, which suggests a more robust market presence than Frx. Meanwhile, The Botanist and Superflux have not consistently ranked in the top 20, indicating potential volatility or niche market focus. Despite these challenges, Frx's sales figures show a stable trajectory, suggesting a loyal customer base that could be leveraged for future growth in this competitive market.
Notable Products
In March 2025, the top-performing product from Farmaceutical Rx (Frx) was Milkbone (2.83g) in the Flower category, maintaining its consistent rank at number one, despite a decrease in sales to 1672 units. Milkbone Smalls (14.15g), also in the Flower category, showed significant improvement, climbing from fifth in February to second place in March, with sales increasing to 1395 units. Banana Platinum OG Live Resin Sugar (1g) entered the rankings for the first time in March, securing the third spot in the Concentrates category. White Truffle (2.83g) made its debut in fourth place within the Flower category. The Espresso Dark Chocolate Bar 10-Pack (220mg) completed the top five, marking its first appearance in the rankings for Edibles.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
